Downregulation of microRNA miR-526a by enterovirus inhibits RIG-I-dependent innate immune response

Journal of Virology

Volumn 88, Issue 19, 2014, Pages 11356-11368

  Xu, Changzhi ^a,b   He, Xiang ^a   Zheng, Zirui ^a,b   Zhang, Zhe ^a   Wei, Congwen ^a   Guan, Kai ^a   Hou, Lihua ^a   Zhang, Buchang ^b   Zhu, Lin ^b   Cao, Yuan ^c   Zhang, Yanhong ^a   Cao, Ye ^a   Ma, Shengli ^a   Wang, Penghao ^a   Zhang, Pingping ^a,c   Xu, Quanbin ^a   Ling, Youguo ^a   Yang, Xiao ^a   Zhong, Hui ^a  

^a BEIJING INSTITUTE OF BIOTECHNOLOGY   (China)

^b ANHUI UNIVERSITY   (China)

^c JINAN MILITARY GENERAL HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON; INTERFERON REGULATORY FACTOR; MICRORNA; MICRORNA 526A; RETINOIC ACID INDUCIBLE PROTEIN I; UNCLASSIFIED DRUG; 3C PROTEASES; CYLD PROTEIN, HUMAN; CYSTEINE PROTEINASE; DDX58 PROTEIN, HUMAN; DEAD BOX PROTEIN; POLYUBIQUITIN; TUMOR SUPPRESSOR PROTEIN; VIRUS PROTEIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYLD GENE; DOWN REGULATION; EMBRYO; ENTEROVIRUS 71; ENTEROVIRUS INFECTION; ENZYME ACTIVITY; ENZYME MECHANISM; ENZYME SYNTHESIS; GENE; GENE EXPRESSION; HUMAN; INNATE IMMUNITY; MACROPHAGE; NONHUMAN; UBIQUITINATION; UPREGULATION; VIRUS REPLICATION; ANIMAL; CHLOROCEBUS AETHIOPS; DOG; ENTEROVIRUS; GENE EXPRESSION REGULATION; GENETICS; HEK293 CELL LINE; HOST PATHOGEN INTERACTION; IMMUNE EVASION; IMMUNOLOGY; MDCK CELL LINE; SIGNAL TRANSDUCTION; VERO CELL LINE; VIROLOGY;

ANIMALS; CERCOPITHECUS AETHIOPS; CYSTEINE ENDOPEPTIDASES; DEAD-BOX RNA HELICASES; DOGS; ENTEROVIRUS A, HUMAN; GENE EXPRESSION REGULATION; HEK293 CELLS; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNE EVASION; IMMUNITY, INNATE; INTERFERON TYPE I; MACROPHAGES; MADIN DARBY CANINE KIDNEY CELLS; MICRORNAS; POLYUBIQUITIN; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEINS; VERO CELLS; VIRAL PROTEINS; VIRUS REPLICATION;

EID: 84906983279     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01400-14     Document Type: Article

References (41)

1. Palacios G, Oberste MS. 2005. Enteroviruses as agents of emerging infectious diseases. J. Neurovirol. 11:424-433. http://dx.doi.org/10.1080 /13550280591002531.
2. McMinn PC. 2002. An overview of the evolution of enterovirus 71 and its clinical and public health significance. FEMS Microbiol. Rev. 26:91-107. http://dx.doi.org/10.1111/j.1574-6976.2002.tb00601.x.
3. Barral PM, Morrison JM, Drahos J, Gupta P, Sarkar D, Fisher PB, Racaniello VR. 2007. MDA-5 is cleaved in poliovirus-infected cells. J. Virol. 81:3677-3684. http://dx.doi.org/10.1128/JVI.01360-06.
4. Barral PM, Sarkar D, Fisher PB, Racaniello VR. 2009. RIG-I is cleaved during picornavirus infection. Virology 391:171-176. http://dx.doi.org /10.1016/j.virol.2009.06.045.
5. Harris KG, Coyne CB. 2013. Enter at your own risk: how enteroviruses navigate the dangerous world of pattern recognition receptor signaling. Cytokine 63:230-236. http://dx.doi.org/10.1016/j.cyto.2013.05.007.
6. Arita M, Wakita T, Shimizu H. 2012. Valosin-containing protein (VCP/p97) is required for poliovirus replication and is involved in cellular protein secretion pathway in poliovirus infection. J. Virol. 86:5541-5553. http://dx.doi.org/10.1128/JVI.00114-12.
7. Lei X, Sun Z, Liu X, Jin Q, He B, Wang J. 2011. Cleavage of the adaptor protein TRIF by enterovirus 71 3C inhibits antiviral responses mediated by Toll-like receptor 3. J. Virol. 85:8811-8818. http://dx.doi.org/10.1128 /JVI.00447-11.
8. Lei X, Xiao X, Xue Q, Jin Q, He B, Wang J. 2013. Cleavage of interferon regulatory factor 7 by enterovirus 71 3C suppresses cellular responses. J. Virol. 87:1690-1698. http://dx.doi.org/10.1128/JVI.01855-12.
9. Lu J, Yi L, Zhao J, Yu J, Chen Y, Lin MC, Kung HF, He ML. 2012. Enterovirus 71 disrupts interferon signaling by reducing the level of interferon receptor 1. J. Virol. 86:3767-3776. http://dx.doi.org/10.1128/JVI .06687-11.
10. Akira S, Takeda K. 2004. Toll-like receptor signalling. Nat. Rev. Immunol. 4:499-511. http://dx.doi.org/10.1038/nri1391.
11. Meylan E, Tschopp J. 2006. Toll-like receptors and RNA helicases: two parallel ways to trigger antiviral responses. Mol. Cell 22:561-569. http://dx .doi.org/10.1016/j.molcel.2006.05.012.
12. Fritz JH, Ferrero RL, Philpott DJ, Girardin SE. 2006. Nod-like proteins in immunity, inflammation and disease. Nat. Immunol. 7:1250-1257. http://dx.doi.org/10.1038/ni1412.
13. Kawai T, Takahashi K, Sato S, Coban C, Kumar H, Kato H, Ishii KJ, Takeuchi O, Akira S. 2005. IPS-1, an adaptor triggering RIG-I-and Mda5-mediated type I interferon induction. Nat. Immunol. 6:981-988. http://dx.doi.org/10.1038/ni1243.
14. Yoneyama M, Kikuchi M, Natsukawa T, Shinobu N, Imaizumi T, Miyagishi M, Taira K, Akira S, Fujita T. 2004. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat. Immunol. 5:730 -737. http://dx.doi.org /10.1038/ni1087.
15. Xu LG, Wang YY, Han KJ, Li LY, Zhai Z, Shu HB. 2005. VISA is an adapter protein required for virus-triggered IFN-beta signaling. Mol. Cell 19:727-740. http://dx.doi.org/10.1016/j.molcel.2005.08.014.
16. Qi B, Huang Y, Rowe D, Halliday G. 2007. VISA-a pass to innate immunity. Int. J. Biochem. Cell Biol. 39:287-291. http://dx.doi.org/10 .1016/j.biocel.2006.08.016.
17. Sun Q, Sun L, Liu HH, Chen X, Seth RB, Forman J, Chen ZJ. 2006. The specific and essential role of MAVS in antiviral innate immune responses. Immunity 24:633-642. http://dx.doi.org/10.1016/j.immuni.2006.04.004.
18. Hiscott J, Lin R, Nakhaei P, Paz S. 2006. MasterCARD: a priceless link to innate immunity. Trends Mol. Med. 12:53-56. http://dx.doi.org/10.1016 /j.molmed.2005.12.003.
19. Seth RB, Sun L, Ea CK, Chen ZJ. 2005. Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. Cell 122:669-682. http://dx.doi.org/10.1016/j.cell .2005.08.012.
20. Bignell GR, Warren W, Seal S, Takahashi M, Rapley E, Barfoot R, Green H, Brown C, Biggs PJ, Lakhani SR, Jones C, Hansen J, Blair E, Hofmann B, Siebert R, Turner G, Evans DG, Schrander-Stumpel C, Beemer FA, van Den Ouweland A, Halley D, Delpech B, Cleveland MG, Leigh I, Leisti J, Rasmussen S. 2000. Identification of the familial cylindromatosis tumour-suppressor gene. Nat. Genet. 25:160-165. http://dx .doi.org/10.1038/76006.
21. Zhang M, Wu X, Lee AJ, Jin W, Chang M, Wright A, Imaizumi T, Sun SC. 2008. Regulation of IkappaB kinase-related kinases and antiviral responses by tumor suppressor CYLD. J. Biol. Chem. 283:18621-18626. http://dx.doi.org/10.1074/jbc.M801451200.
22. Brummelkamp TR, Nijman SM, Dirac AM, Bernards R. 2003. Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NFkappaB. Nature 424:797-801. http://dx.doi.org/10.1038/nature01811.
23. Kovalenko A, Chable-Bessia C, Cantarella G, Israel A, Wallach D, Courtois G. 2003. The tumour suppressor CYLD negatively regulates NF-kappaB signalling by deubiquitination. Nature 424:801-805. http: //dx.doi.org/10.1038/nature01802.
24. Trompouki E, Hatzivassiliou E, Tsichritzis T, Farmer H, Ashworth A, Mosialos G. 2003. CYLD is a deubiquitinating enzyme that negatively regulates NF-kappaB activation by TNFR family members. Nature 424: 793-796. http://dx.doi.org/10.1038/nature01803.
25. Massoumi R, Chmielarska K, Hennecke K, Pfeifer A, Fassler R. 2006. Cyld inhibits tumor cell proliferation by blocking Bcl-3-dependent NFkappaB signaling. Cell 125:665-677. http://dx.doi.org/10.1016/j.cell.2006 .03.041.
26. Hou J, Wang P, Lin L, Liu X, Ma F, An H, Wang Z, Cao X. 2009. MicroRNA-146a feedback inhibits RIG-I-dependent Type I IFN production in macrophages by targeting TRAF6, IRAK1, and IRAK2. J. Immunol. 183:2150-2158. http://dx.doi.org/10.4049/jimmunol.0900707.
27. Nahid MA, Satoh M, Chan EK. 2011. MicroRNA in TLR signaling and endotoxin tolerance. Cell. Mol. Immunol. 8:388-403. http://dx.doi.org /10.1038/cmi.2011.26.
28. Park MS, Shaw ML, Munoz-Jordan J, Cros JF, Nakaya T, Bouvier N, Palese P, Garcia-Sastre A, Basler CF. 2003. Newcastle disease virus (NDV)-based assay demonstrates interferon-antagonist activity for the NDV V protein and the Nipah virus V, W, and C proteins. J. Virol. 77: 1501-1511. http://dx.doi.org/10.1128/JVI.77.2.1501-1511.2003.
29. Wei C, Ni C, Song T, Liu Y, Yang X, Zheng Z, Jia Y, Yuan Y, Guan K, Xu Y, Cheng X, Zhang Y, Yang X, Wang Y, Wen C, Wu Q, Shi W, Zhong H. 2010. The hepatitis B virus X protein disrupts innate immunity by downregulating mitochondrial antiviral signaling protein. J. Immunol. 185:1158-1168. http://dx.doi.org/10.4049/jimmunol.0903874.
30. Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-ΔΔCT) method. Methods 25:402-408. http://dx.doi.org/10.1006/meth.2001.1262.
31. Cui S, Eisenacher K, Kirchhofer A, Brzozka K, Lammens A, Lammens K, Fujita T, Conzelmann KK, Krug A, Hopfner KP. 2008. The C-terminal regulatory domain is the RNA 5=-triphosphate sensor of RIG-I. Mol. Cell 29:169-179. http://dx.doi.org/10.1016/j.molcel.2007.10.032.
32. Komuro A, Bamming D, Horvath CM. 2008. Negative regulation of cytoplasmic RNA-mediated antiviral signaling. Cytokine 43:350-358. http://dx.doi.org/10.1016/j.cyto.2008.07.011.
33. Zhang M, Tian Y, Wang RP, Gao D, Zhang Y, Diao FC, Chen DY, Zhai ZH, Shu HB. 2008. Negative feedback regulation of cellular antiviral signaling by RBCK1-mediated degradation of IRF3. Cell Res. 18:1096-1104. http://dx.doi.org/10.1038/cr.2008.277.
34. Takeuchi O, Akira S. 2009. Innate immunity to virus infection. Immunol. Rev. 227:75-86. http://dx.doi.org/10.1111/j.1600-065X.2008.00737.x.
35. Friedman CS, O'Donnell MA, Legarda-Addison D, Ng A, Cardenas WB, Yount JS, Moran TM, Basler CF, Komuro A, Horvath CM, Xavier R, Ting AT. 2008. The tumour suppressor CYLD is a negative regulator of RIG-I-mediated antiviral response. EMBO Rep. 9:930-936. http://dx.doi .org/10.1038/embor.2008.136.
36. Hashimoto K, Mori N, Tamesa T, Okada T, Kawauchi S, Oga A, Furuya T, Tangoku A, Oka M, Sasaki K. 2004. Analysis of DNA copy number aberrations in hepatitis C virus-associated hepatocellular carcinomas by conventional CGH and array CGH. Modern Pathol. 17:617-622. http: //dx.doi.org/10.1038/modpathol.3800107.
37. Hellerbrand C, Bumes E, Bataille F, Dietmaier W, Massoumi R, Bosserhoff AK. 2007. Reduced expression of CYLD in human colon and hepatocellular carcinomas. Carcinogenesis 28:21-27. http://dx .doi.org/10.1093/carcin/bgl081.
38. Jenner MW, Leone PE, Walker BA, Ross FM, Johnson DC, Gonzalez D, Chiecchio L, Dachs Cabanas E, Dagrada GP, Nightingale M, Protheroe RK, Stockley D, Else M, Dickens NJ, Cross NC, Davies FE, Morgan GJ. 2007. Gene mapping and expression analysis of 16q loss of heterozygosity identifies WWOX and CYLD as being important in determining clinical outcome in multiple myeloma. Blood 110:3291-3300. http://dx.doi.org /10.1182/blood-2007-02-075069.
39. Chen C, Ridzon DA, Broomer AJ, Zhou Z, Lee DH, Nguyen JT, Barbisin M, Xu NL, Mahuvakar VR, Andersen MR, Lao KQ, Livak KJ, Guegler KJ. 2005. Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res. 33:e179. http://dx.doi.org/10.1093/nar /gni178.
40. Tsitsiou E, Lindsay MA. 2009. MicroRNAs and the immune response. Curr. Opin. Pharmacol. 9:514-520. http://dx.doi.org/10.1016/j.coph .2009.05.003.
41. Zheng Z, Ke X, Wang M, He S, Li Q, Zheng C, Zhang Z, Liu Y, Wang H. 2013. Human microRNA hsa-miR-296-5p suppresses enterovirus 71 replication by targeting the viral genome. J. Virol. 87:5645-5656. http://dx .doi.org/10.1128/JVI.02655-12.